CDC report details risk profiles and symptom duration in post-acute COVID-19 syndrome

Recent CDC surveillance reports place the share of US adults who have ever had Long COVID at 6.9 percent as of mid-2023, with 4.4 percent still reporting symptoms at the time of the survey. These figures come from large-scale household surveys that track symptoms persisting beyond four weeks after acute infection. The data also identify consistent patterns in who faces elevated risk and how prior vaccination relates to shorter symptom duration.

Prevalence estimates

National Health Interview Survey results show that roughly one in fourteen adults has experienced Long COVID at least once. Current prevalence stands near one in twenty-three adults. These estimates rest on self-reported data collected across multiple waves of the survey.

Risk factor patterns

Three CDC analyses link higher Long COVID odds to female sex, preexisting conditions such as diabetes or obesity, and socioeconomic markers including lower income or unemployment. Adults without COVID-19 vaccination also showed elevated rates compared with those who received at least one dose. The same reports note that symptom duration tended to be shorter among vaccinated respondents.

Vaccination and duration findings

One MMWR analysis examined symptom length directly and found that vaccinated adults reported fewer weeks of ongoing symptoms after infection. The reduction held after adjustment for age and other variables in the household pulse survey sample.

What this means

The numbers point to a stable burden of prolonged symptoms across the adult population, concentrated among identifiable groups. They also show vaccination as one factor associated with lower incidence and shorter course of symptoms.

Limitations

Survey responses rely on recall and self-identification, which can shift with changing public awareness. Case definitions differ slightly across the three reports, and certain hard-to-reach groups remain underrepresented. Observational designs cannot establish direct causation between any single factor and symptom persistence.

Key takeaways

An estimated 6.9 percent of US adults reported ever having Long COVID, while 4.4 percent had symptoms at the time of the 2023 survey [1].
Female sex, chronic conditions such as heart disease or diabetes, and socioeconomic disadvantage appear repeatedly as risk markers [2].
At least one COVID-19 vaccine dose correlates with lower Long COVID incidence and reduced symptom duration [3].
All prevalence figures derive from self-reported national surveys rather than clinical confirmation.
Observational data limit conclusions about why certain groups show higher rates.

Last updated: September 2, 2026